Intravenous regional guanethidine treatment in peripheral vascular disease. 1980

D Olshwang, and G Beer, and F Magora

Twenty-eight patients with spastic and obstructive vascular disease were treated with intravenous regional guanethidine (IRG). The drug was injected into the affected hand or foot in doses of 10 or 20 mg, respectively. Temperature and strain-gauge plethysmography curves of the extremity were recorded before treatment, and three to four times during the subsequent 10 days. The effects of IRG, as observed by clinical laboratory examinations, were good in 8 of 12 patients. But in patients suffering from Bürger's disease or from major vessel obstructive disease, the results were not as good. However, in most patients IRG proved beneficial in relieving pain, an effect which sometimes outlasted objective improvements. IRG treatment is a simple and safe method for prolonged chemical sympathectomy.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D005260 Female Females
D006145 Guanethidine An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,Guanethidine Monosulfate,Guanethidine Sulfate,Guanethidine Sulfate (1:1),Guanethidine Sulfate (1:2),Guanethidine Sulfate (2:1),Guanethidine Sulfate (2:1), 14C-Labeled,Ismelin,Isobarin,Octadine,Oktadin,Monosulfate, Guanethidine,Sulfate, Guanethidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Olshwang, and G Beer, and F Magora
January 1982, Annales de chirurgie de la main : organe officiel des societes de chirurgie de la main,
D Olshwang, and G Beer, and F Magora
December 1991, Clinical rheumatology,
D Olshwang, and G Beer, and F Magora
December 1982, Revue du rhumatisme et des maladies osteo-articulaires,
D Olshwang, and G Beer, and F Magora
May 1988, Cahiers d'anesthesiologie,
D Olshwang, and G Beer, and F Magora
July 1979, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D Olshwang, and G Beer, and F Magora
May 1974, Lancet (London, England),
D Olshwang, and G Beer, and F Magora
February 1942, British medical journal,
D Olshwang, and G Beer, and F Magora
June 1974, Lancet (London, England),
D Olshwang, and G Beer, and F Magora
June 1993, Journal of hand surgery (Edinburgh, Scotland),
D Olshwang, and G Beer, and F Magora
May 1977, Lancet (London, England),
Copied contents to your clipboard!